Clinical Trials Logo

Clinical Trial Summary

The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters during atrial fibrillation ablation. By increasing the efficacy of radiofrequency energy-mediated lesion formation, half-normal saline has the potential to reduce procedural times and improved acute and long-term outcomes.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03498586
Study type Interventional
Source Texas Cardiac Arrhythmia Research Foundation
Contact
Status Not yet recruiting
Phase N/A
Start date April 2018
Completion date April 2020

See also
  Status Clinical Trial Phase
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT03313167 - Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate
Recruiting NCT03593486 - Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation N/A
Enrolling by invitation NCT03259373 - IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation N/A
Completed NCT02878213 - DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness N/A
Active, not recruiting NCT03765242 - Evaluation of Safety and Effectiveness on Oral Anticoagulants
Not yet recruiting NCT03455673 - Exclusion of Intra-atrial Thrombus Before Catheter Ablation
Not yet recruiting NCT03620656 - The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation
Not yet recruiting NCT03243175 - Avoiding Anticoagulation After IntraCerebral Haemorrhage Phase 3
Not yet recruiting NCT02808260 - Predicting Development of SCAF in Device Patients
Not yet recruiting NCT03645564 - Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department N/A
Not yet recruiting NCT03503812 - Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches N/A
Recruiting NCT02914860 - Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology Phase 1/Phase 2
Recruiting NCT02923414 - Comparison of High Versus Escalating Shocks in Cardioverting Atrial Fibrillation N/A
Recruiting NCT02892578 - Systematic Screening With Electrocardiogram for Unknown Atrial Fibrillation in 65 Years Old and Above People in Nursing Home N/A
Recruiting NCT02982434 - The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Phase 2
Recruiting NCT02896595 - General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation N/A
Recruiting NCT02916550 - Breathing Intervention for Cardiac Anxiety N/A
Enrolling by invitation NCT02905032 - SDM for Stroke Prevention in Atrial Fibrillation N/A
Not yet recruiting NCT02817815 - Atrial Fibrillation and Characterization of Blood Platelet N/A